n-methylaspartate has been researched along with clobenpropit in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Z; Dai, H; Fu, Q; Hu, W; Leurs, R; Shen, Y; Timmerman, H; Zhang, Z | 1 |
1 other study(ies) available for n-methylaspartate and clobenpropit
Article | Year |
---|---|
The histamine H3 receptor antagonist clobenpropit enhances GABA release to protect against NMDA-induced excitotoxicity through the cAMP/protein kinase A pathway in cultured cortical neurons.
Topics: Animals; Animals, Newborn; Calcium; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytoprotection; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Histamine Agonists; Histamine Antagonists; Imidazoles; N-Methylaspartate; Necrosis; Neurons; Neuroprotective Agents; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Thiourea | 2007 |